Exelixis Catapults 14% On Positive Results For Next-Gen Colon Cancer Drug

investors.com/news/technology/exelixis-stock-next-generation-cancer-drug-colon-cancer

Exelixis stock surged Monday after the company said its next-generation cancer drug showed promise in a colon cancer study.
The post Exelixis Catapults 14% On Positive Results For Next-Gen Colon Cancer Drug appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-23 13:36:44.
The Entire Business World on a Single Page. Free to Use →